Schedule 1 - International Brand Licensing plc
18 Junio 2010 - 9:03AM
UK Regulatory
TIDMIBL
RNS Number : 8898N
AIM
18 June 2010
+---------------------------------------------------------------------+
| ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION |
| IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM |
| RULES") |
+---------------------------------------------------------------------+
| |
+---------------------------------------------------------------------+
| COMPANY NAME: |
+---------------------------------------------------------------------+
| |
| International Brand Licensing plc (to be renamed EKF Diagnostics |
| Holdings plc) |
+---------------------------------------------------------------------+
| COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY |
| TRADING ADDRESS (INCLUDING POSTCODES) : |
+---------------------------------------------------------------------+
| |
| 14 Kinnerton Place South, London SW1X 8EH |
+---------------------------------------------------------------------+
| COUNTRY OF INCORPORATION: |
+---------------------------------------------------------------------+
| England and Wales |
| |
+---------------------------------------------------------------------+
| COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY |
| AIM RULE 26: |
+---------------------------------------------------------------------+
| www.iblplc.com |
| |
+---------------------------------------------------------------------+
| COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN |
| THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING |
| POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE |
| TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: |
+---------------------------------------------------------------------+
| The Admission is the result of a reverse takeover through the |
| acquisition by International Brand Licensing plc of |
| EKF-diagnostic GmbH ("EKF"). |
| |
| The existing business of International Brand Licensing plc is |
| focused on exploiting a portfolio of sports and lifestyle |
| brands, trade names and logos by granting licences to third |
| parties allowing them to manufacture, market and sell products |
| in pre determined territories across the world. The Directors |
| intend to dispose of the company's licensing business as |
| opportunities arise over the coming months. |
| |
| The EKF Group comprises established businesses with operations |
| in Germany, Poland and Russia which are focused on the design, |
| development, manufacture and selling of diagnostic instruments |
| and reagents. EKF's products and devices are designed to meet |
| the needs of smaller professional clinical and research |
| laboratories, doctor's offices, sports clinics and athletic |
| testing sites. |
| |
| |
+---------------------------------------------------------------------+
| DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS |
| AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and |
| type of shares, nominal value and issue price to which it seeks |
| admission and the number and type to be held as treasury |
| shares): |
+---------------------------------------------------------------------+
| |
| A total of 100,435,653 new ordinary shares of 1 pence each and |
| re admission of 41,991,653 existng ordinary shares of 1 pence |
| each |
| |
| The shares are expected to be admitted on three separate dates: |
| |
| First admission (first tranche placing shares): 10,666,665 new |
| ordinary shares of 1 pence each |
| |
| Second admission (second tranche placing shares): 25,499,998 new |
| ordinary shares of 1 pence each |
| |
| Third admission (third tranche placing shares and re admission |
| of existing ordinary shares): 64,268,990 new ordinary shares of |
| 1 pence each and re admission of all existing ordinary shares |
| |
| |
+---------------------------------------------------------------------+
| CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND |
| ANTICIPATED MARKET CAPITALISATION ON ADMISSION: |
+---------------------------------------------------------------------+
| GBP 15.06 million |
| Market Capitalisation expected to be GBP21.36 million on |
| Admission |
| |
+---------------------------------------------------------------------+
| PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION: |
+---------------------------------------------------------------------+
| |
| 29.94% |
| |
+---------------------------------------------------------------------+
| DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE |
| AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES |
| (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED: |
+---------------------------------------------------------------------+
| N/a |
| |
+---------------------------------------------------------------------+
| FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS |
| (underlining the first name by which each is known or including |
| any other name by which each is known): |
+---------------------------------------------------------------------+
| Directors |
| David Eric Evans (Non-Executive Chairman) |
| Julian Huw Baines (Chief Executive Officer) |
| Paul Andrew Peter Foulger (Finance Director) |
| Adam Reynolds (Non-Executive Director) |
| Gordon James Hall (Non-Executive Director) |
| Dr Kevin William Wilson (Non-Executive Director) |
+---------------------------------------------------------------------+
| FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS |
| A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER |
| ADMISSION (underlining the first name by which each is known or |
| including any other name by which each is known): |
+---------------------------------------------------------------------+
| Name Number % of Number % of |
| of the of issued |
| Ordinary Issued Ordinary Share |
| Shares Ordinary Shares Capital |
| prior to Share following following |
| Admission Capital Admission Admission |
| prior to |
| Admission |
| Legal & General 15.45 |
| - 22,000,000 |
| Octopus Asset - 10.53 |
| Management - 15,000,000 |
| - 7.49 |
| Hargreave Hale - 10,666,666 |
| - 5.85 |
| Ignis Asset - 8,333,333 |
| Management - |
| 17.04 5.02 |
| HSBC Global 7,153,693 |
| Custody Nominee 7,153,693 |
| (UK) Ltd BH01 13.31 3.92 |
| 883031 5,590,000 |
| 5,590,000 |
| Newedge Group 7.21 2.12 |
| SA 2093110 3,026,403 |
| 3,026,403 4.07 1.20 |
| JM Finn Nominees 1,708,480 |
| Ltd 1,708,480 3.62 1.07 |
| 1,521,243 |
| Lance Yates Esq 1,521,243 |
| (Estate of) 3.23 0.95 |
| 1,357,127 |
| Pershing Nominees 1,357,127 3.14 0.93 |
| Ltd 1,318,000 |
| BFCLT 1,318,000 |
| 3.04 0.89 |
| Julian Baines 1,274,472 |
| 1,274,472 |
| The Bank of New |
| York (Nominees) |
| Limited |
| |
| James Capel |
| (Nominees) Limited |
| |
| |
+---------------------------------------------------------------------+
| NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE |
| 2, PARAGRAPH (H) OF THE AIM RULES: |
+---------------------------------------------------------------------+
| N/a |
| |
+---------------------------------------------------------------------+
| (i) ANTICIPATED ACCOUNTING |
| REFERENCE DATE |
| (ii) DATE TO WHICH THE MAIN |
| FINANCIAL INFORMATION IN THE ADMISSION |
| DOCUMENT HAS BEEN PREPARED (this may be |
| represented by unaudited interim |
| financial information) |
| (iii) DATES BY WHICH IT MUST |
| PUBLISH ITS FIRST THREE REPORTS PURSUANT |
| TO AIM RULES 18 AND 19: |
+---------------------------------------------------------------------+
| |
| (i) 31 December |
| (ii) 31 December 2009 |
| (in relation to EKF); |
| financial information in |
| relation to International |
| Brand Licensing plc has been |
| omitted in accordance with |
| Rule 28 |
| (iii) 30 September |
| 2010, 30 June 2011, 30 |
| September 2011 |
| |
+---------------------------------------------------------------------+
| EXPECTED ADMISSION DATE: |
+---------------------------------------------------------------------+
| 7 July 2010 |
| |
+---------------------------------------------------------------------+
| NAME AND ADDRESS OF NOMINATED ADVISER: |
+---------------------------------------------------------------------+
| Zeus Capital Limited |
| 3 Ralli Courts |
| West Riverside |
| Manchester M3 5FT |
| |
+---------------------------------------------------------------------+
| NAME AND ADDRESS OF BROKER: |
+---------------------------------------------------------------------+
| Joint Brokers: |
| Zeus Capital Limited |
| 3 Ralli Courts |
| West Riverside |
| Manchester M3 5FT |
| |
| Matrix Corporate Capital LLP |
| One Vine Street |
| London |
| W1J 0AH |
| |
+---------------------------------------------------------------------+
| OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE |
| (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE |
| AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL |
| DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: |
+---------------------------------------------------------------------+
| www.iblplc.com The admission document contains full details |
| about the company and the admission of its securities. |
+---------------------------------------------------------------------+
| DATE OF NOTIFICATION: |
+---------------------------------------------------------------------+
| 18 June 2010 |
| |
+---------------------------------------------------------------------+
| NEW/ UPDATE: |
+---------------------------------------------------------------------+
| New |
| |
+---------------------------------------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
PAAEALKPFEAEEFF
International Brand Licensing (LSE:IBL)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
International Brand Licensing (LSE:IBL)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
